CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SafePolyMed aims to enhance patient safety in polypharmacy and multimorbidity by developing a framework to assess and manage drug-drug-gene interactions. It utilizes machine learning and patient engagement tools to identify risks, educate patients, and support physicians in optimizing treatment regimens.
Polypharmacy, multimorbidity and genetic heterogeneity can affect drug efficacy, raise the risk for adverse drug reactions (ADRs) and increase healthcare costs. ADRs are among the leading causes of death in developed countries and a major cause of hospitalization.
Drug-drug interactions (DDIs) and drug-gene interactions (DGIs) are highly interconnected and require a holistic approach to improve safety of our citizens.
However, investigations on real-life drug-drug-gene interactions (DDGIs) in cl…
UNIVERSITAT DES SAARLANDES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Aachen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
FOUNDATION FOR RESEARCH AND TECHNOLOGYHELLAS
Greece, Irakleio
Type: Research institute
Activity type: Research Organisations
SME: No
Estonia, Tartu
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
